Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Dysarthria

Dysarthria is a motor speech disorder resulting from neurological injury, characterised by poor articulation . Any of the speech subsystems can be affected. Disarthic speech is due to some disorder in the nervous system, which in turn hinders control over, for example, tongue, throat, lips or lungs. Swallowing problems, dysphagia, are often present.Cranial nerves that control these muscles include the facial nerve , the glossopharyngeal nerve , the vagus nerve , and the hypoglossal nerve . (From the Wikpedia article Dysarthria.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Dysarthria:

Pubmed Logo
The Redesign and Re-evaluation of an Internet-Based Telerehabilitation System for the Assessment of Dysarthria in Adults.
A previous study revealed that reliable assessment of dysarthria was...
19th November, 2009
Division of Speech Pathology. Telemed J E Health. 2009 Nov;15(9):840-850.
DOI Direct Link
A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer's disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF.
Background and purpose: A novel presenilin1 (PSEN1) mutation associated...
17th November, 2009
Department of Neurology, University Hospital, Ulm, Germany. Eur J Neurol. 2009 Nov 12.
DOI Direct Link
Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.
BACKGROUND: Central nervous system (CNS) complications of Langerhans cell...
13th November, 2009
Texas Children's Cancer Center/Hematology Service, Houston, Texas. Pediatr Blood Cancer. 2009 Nov 11.
DOI Direct Link
A pernicious leucoencephalopathy.
Pernicious anaemia may manifest various neurological symptoms and signs...
12th November, 2009
Department of Neurology, St Vincent's University Hospital, Elm Park, Ir Med J. 2009 Oct;102(9):292-4.
Childhood chorea with cerebral hypotrophy: a treatable GLUT1 energy failure syndrome.
OBJECTIVE: To expand the spectrum of glucose transporter type 1 deficiency...
11th November, 2009
Department of Neurology, Hospital Universitari Sant Joan de Deu, Arch Neurol. 2009 Nov;66(11):1410-4.
DOI Direct Link

View more research publications.

Dysarthria Patents:

USPTO Logo
US Patent No.Title
7368531 Human secreted proteins
7446176 12 human secreted proteins
7446181 Antibodies that bind human Dickkopf-1 proteins
7449575 Substituted diamino-1,3,5-triazine derivatives
7459156 Antibodies that mimic actions of neurotrophins

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Dysarthria scientists - we have details of around 314 individuals working on Dysarthria .


This page has been viewed 520 times
Recent Search Terms used to find this page: sample speech report dysarthria | Dysarthria Glossopharyngeal Nerve | dysarthria videos | dysarthria video | dysarthria videos | disarthic | dysarthria r s | Dysarthria videos | pyridazinyl wikipedia | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Dysarthria across BioPortfolio, or for Dysarthria Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.